© Copyright
WELCOME TO THE ANNUAL GENERAL MEETING 2019
Rice PowellChief Executive Officer
5/16/2019Annual General Meeting 2019 Page 2
OUR PURPOSE
5/16/2019Annual General Meeting 2019 Page 3
OUR PASSION
Patients treated
Dialysis treatments
>330,000
~50million
>3,900
Dialysis centers
+14%change4
+14%change4
+4%change4
5/16/2019Annual General Meeting 2019 Page 4
OUR SUCCESS IN NUMBERS: KEY FIGURES 2018
Net income2
on a comparable basis3
2018
1.38BN €
2018
16.55BN €
Revenueon a comparable basis1
1) 2017 adjusted for the effect of IFRS 15 implementation and the contribution of Sound Physicians in H2 2017 │ 2) Net income attributable to shareholders of Fresenius Medical Care AG & Co. KGaA │ 3) Adjusted for the contribution from Sound Physicians in H2 2017 and in 2018 for the gain related to divestitures of Care Coordination activities, the FCPA related charge and contributions to the opposition to the ballot initiatives in the U.S. │ 4) at constant currency
Basic earnings per shareon a comparable basis3
2018
4.49€
1.10
1.00
0.90
0.80
0.70
0.60
0.50
5/16/2019Annual General Meeting 2019 Page 5
CONTINUING THE HISTORY: 22ND CONSECUTIVE DIVIDEND INCREASE
2016
0.96€
+10%change
2017
1.06€
2018
1.17€
2015
0.80€
2014
0.78€
5/16/2019Annual General Meeting 2019 Page 6
HOLISTIC CARE FOR AN INCREASING NUMBER OF PATIENTS
vv
5/16/2019Annual General Meeting 2019 Page 7
FOR YOUR BENEFIT: SHARE BUY-BACK PROGRAM
1BN €
over the next two years
Up to
5/16/2019Annual General Meeting 2019 Page 8
DRIVING THE CHANGE: VALUE-BASED CARE
ESCO program in the U.S. (ESRD Seamless Care Organization)
State-run health care program
Seamless care for dialysis patients
We are the largest provider in this program
We care for
80% of all ESCO
patients
Improvedtreatmentoutcomes
6%decrease
inhospitaldays
Adaptto
patients’needs
5/16/2019Annual General Meeting 2019 Page 9
DRIVING THE CHANGE: HOME DIALYSIS
Wide range of therapy options
Patients’ choice of treatment
location
G O A L
Improve quality of
lifeSelf-determined
5/16/2019Annual General Meeting 2019 Page 10
THRIVING ON HOME CARE WITH NXSTAGE
5/16/2019Annual General Meeting 2019 Page 11
OUR HOME DIALYSIS PATIENTS IN THE U.S.
Moreflexibility
Lowercost2018
2022e
12%
15%+
Highersatisfaction
Increasedautonomy
5/16/2019Annual General Meeting 2019 Page 12
FURTHER ENHANCING OUR PRODUCT PORTFOLIO
5/16/2019Annual General Meeting 2019 Page 13
ENTERING NEW MARKETS: SPOTLIGHT ON CHINA
5/16/2019Annual General Meeting 2019 Page 14
PIONEERING INNOVATIONS: REGENERATIVE MEDICINE
Lower risk of complications
Lastslonger
Higherresilience
Fewer medicalprocedures
Cooperation with Humacyte
U.S. biotech company developing an artificially engineered blood vessel based on human cells
Available to more hemodialysis patients upon approval
5/16/2019Annual General Meeting 2019 Page 15
113,000 REASONS FOR SUCCESS: OUR EMPLOYEES
O U RF U T U R E
Innovation
Benefitof our
patients
5/16/2019Annual General Meeting 2019 Page 16
INVESTING IN OUR FUTURE
Areas of growth
Efficiency
5/16/2019Annual General Meeting 2019 Page 17
SPOTLIGHT: OUR NEW GLOBAL MEDICAL OFFICE
L a u n c h e d
March2019
Betteroutcomes
Coordinate and evaluate data from
clinical research and medical practice
For the benefit of our patients
and the health care system
Develop improved treatments
5/16/2019Annual General Meeting 2019 Page 18
OUTLOOK1
(cc)Targets 2019 2018 Base
in M €
Revenue growth adjusted 3 to 7% 16,026
Net income growth adjusted (2) to 2% 1,341
(cc)Targets 2020
Revenue growth adjusted Mid-to-high single-digit growth rate
Net income growth adjusted Mid-to-high single-digit growth rate
cc = constant currency
1) Targets for 2019 and 2020 are in constant currency. These targets as well as the 2018 base are and will be adjusted in order to make the business performance in the respective periodscomparable for items such as: FCPA related charges, the IFRS 16 implementation, the contributions from Sound in H1 2018, the gain (loss) related to divestitures of Care Coordinationactivities and expenses for the cost optimization program. All effects from the NxStage acquisition are excluded from the targets for 2019 and 2020.
5/16/2019Annual General Meeting 2019 Page 19
OUR PURPOSE
© Copyright
ANNUAL GENERAL MEETING 2019
Thank you.